| |
|
|
|
| |
How to Ensure the Best Chance of Success for Your Therapeutic Proteins Program Life Science Leader – November 5, 2009
The exciting field of biotechnology-derived therapeutic proteins, or biologics, has the potential to yield important medical breakthroughs in just about every branch of medicine. However, due to the size and complexity of these unique therapeutic proteins, the process for safely overcoming regulatory hurdles and bringing a biologic to market is vastly different from the processes for any other type of pharmaceutical. This problem is compounded due to the fact that the drug development process for individual biologics also differ greatly from each other and that no clear regulatory guidance exists for each type of biologics...Read the full article.
|
|
biotechnology-derived therapeutics, therapeutic proteins, biologic development, charles river preclinical services, pharmacology, safety evaluation, toxicity and safety parameters,
How to Ensure the Best Chance of Success for Your Therapeutic Proteins Program | Life Science Leader (November 2009)
The exciting field of biotechnology-derived therapeutic proteins, or biologics, has the potential to yield important medical breakthroughs in just about every branch of medicine.